We treated HT-29 human colorectal adenocarcinoma cells with UDCA and found that UDCA inhibited G protein-coupled receptor (GPCR) CXCR4 expression (Fig. S9). This evidence concerns the gene CXCR4 and colorectal adenocarcinoma.